BCMA-vHH-Nluc fusion protein showed significant binding to BCMA-expressing Myeloma cell lines (MM1S and L363), when compared with BCMA-negative HL60 and Jurkat cell lines (Fig. 8). The gene discussed is TNFRSF17; the disease is plasma cell myeloma.